Cardiovascular disease: An infectious aetiology?

Reviews and Research in Medical Microbiology

Volumn 9, Issue 1, 1998, Pages 17-27

  Coles, Katie A ^a   Plant, Aileen J ^a   Riley, Thomas V ^a,b   Smith, David W ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Atherosclerosis; Cardiovascular disease; Chlamydia pneumoniae; Cytomegalovirus; Helicobacter pylori; Immunopathology

Indexed keywords

CHOLESTEROL;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CYTOMEGALOVIRUS; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; STROKE;

EID: 0031983543     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199801000-00003     Document Type: Review

References (15)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-1315.
2. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83: 640-643.
3. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
4. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia TWAR, with chronic heart disease and acute myocardial infarction. Lancet 1988; ii: 983-986.
5. Saikku P, Leinonen M, Thkanen L et al. Chronic Chlamydia pneumonia infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273-278.
6. Thom PH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of a prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.
7. Kuo CC, Shor A, Campbell LA, Tukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849.
8. Grayston JT, Kuo CC, Coulson AS et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-3400.
9. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit oxidative modification of low density lipoprotein. Atherosclerosis 1990; 82: 185-191.
10. Fowkes FG. Fibrinogen and cardiovascular disease in clinical practice. Eur Heart J 1995; 16(suppl A): 60-63.
11. Blake GH, Abell TD, Stanley WG. Cigarette smoking and upper respiratory tract infections in basic combat training. Ann Intern Med 1988; 109: 198-202.
12. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb 1992; 12: 945-947.
13. Roblin PM, Montalban G, Hammerschlagg MR. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrob Agents Chemother 1994; 38: 1588-1589.
14. Bell GD, Bate CM, Axon AT et al. Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole. Aliment Pharmacol Therapeut 1996; 10: 637-644.
15. Desatnik HR, Foster RE, Lowder CY. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet. Am J Ophthalmol 1996; 122: 121-123.